Putnam Investments’s Veradigm Inc. Common Stock MDRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
$1.17M Buy
111,099
+1,659
+2% +$20.3K ﹤0.01% 826
2023
Q3
$1.44M Sell
109,440
-956
-0.9% -$12.5K ﹤0.01% 783
2023
Q2
$1.39M Sell
110,396
-561,456
-84% -$6.82M ﹤0.01% 804
2023
Q1
$8.77M Buy
671,852
+551,077
+456% +$8.92M 0.01% 332
2022
Q4
$2.13M Sell
120,775
-2,262
-2% -$37.9K ﹤0.01% 708
2022
Q3
$1.87M Sell
123,037
-9,187
-7% -$149K ﹤0.01% 746
2022
Q2
$1.96M Buy
+132,224
New +$2.47M ﹤0.01% 748
2022
Q1
Sell
-30,134
Closed -$556K 1287
2021
Q4
$556K Buy
+30,134
New +$479K ﹤0.01% 943

Other funds holding MDRX

Putnam Investments's MDRX Position: Q4 2023 in Review

Putnam Investments increased its Veradigm Inc. Common Stock (MDRX) stake by 1.5% in Q4 2023, buying an estimated $20.3K and bringing the position to 111,099 shares worth $1.17M. The position accounts for ﹤0.01% of the portfolio, ranked #826.

Putnam Investments first reported a position in MDRX in Q4 2021 and has held it in 8 quarters since. The position peaked at $8.77M in Q1 2023. 225 funds tracked by Wall St. Rank hold MDRX as of Q4 2023.

  • Putnam Investments held 111,099 shares of Veradigm Inc. Common Stock worth $1.17M as of Q4 2023.
  • Putnam Investments bought 1,659 Veradigm Inc. Common Stock shares in Q4 2023, an estimated $20.3K.
  • Veradigm Inc. Common Stock made up ﹤0.01% of Putnam Investments's portfolio in Q4 2023, its #826 holding.
  • Putnam Investments first reported a position in Veradigm Inc. Common Stock in Q4 2021 and has held it in 8 quarters since.
  • Putnam Investments's Veradigm Inc. Common Stock position peaked at $8.77M in Q1 2023.
  • 225 funds tracked by Wall St. Rank held Veradigm Inc. Common Stock as of Q4 2023.

Based on Putnam Investments's 13F filing for Q4 2023, filed 14 Feb 2024.